VivoSeq
Cardiovascular

Cerebral Venous Sinus Thrombosis

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Cerebral Venous Sinus Thrombosis is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

2

clinical trials

Recruiting1 · 50%
Unknown status1 · 50%

Clinical Trials

Trial Activity

Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)
Recruiting·—·N/A·NCT06583889·224 enrolled
The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis
Unknown status·—·Phase 4·NCT04269954·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)